Jennewein Biotechnologie is a leading producer of complex oligosaccharides, focusing on human milk oligosaccharides (HMOs). In July 2018, Jennewein Biotechnologie will launch its first clinical trial of an infant formula containing the five most abundant […]
Azitra Inc. today announced that it has secured $2.15 million in convertible debt financing to support advancement of the company’s pipeline of dermatology and skin care products. The financing was led by new investor Connecticut […]
Eagle Genomics has appointed Executive Chairman Anthony Finbow to the post of Chief Executive, with founder Abel Ureta-Vidal moving to become Chief Product Officer. The change in management structure marks a new phase for Eagle […]
A-Mansia Biotech S.A. (A-Mansia), the microbiome company focused on developing products based on the unique properties of the Akkermansia muciniphila (A. muciniphila) bacterium, today announces a €13 million first close of its Series A financing, […]
In the presence of Mrs. Elsbieta Bienkowska, European Commissioner Internal Market, Industry, Entrepeneurship and SMEs, and Mrs. Mona Keijzer, State Secretary Economic Affairs & Climate Policy, 12 finalists pitched their inspiring innovations to tackle global […]
The Global Prebiotic Association (GPA), the association formed to steward growth of the category, today announced that Prenexus Health, Hayashibara (Nagase), Nutrasource Diagnostics and KGK Science have joined the organization. GPA has also added dietitian […]
The fight against the increasing and serious antibiotic resistance, that kills more and more people, is carried on many fronts. Organizations such as Strama and ReAct, as well as the Public Health Authority, work on […]
Comments from the Managing Director: “Sales for the first quarter of 2018 amounted to SEK 157 million, which was an increase of 13% (excluding foreign exchange effects) compared to the corresponding period last year. Revenue […]
When compared with nondrinkers, men and women who had one or more alcoholic drinks per day had an overabundance of oral bacteria linked to gum disease, some cancers, and heart disease. By contrast, drinkers had […]
Synthetic Biologics, Inc. (NYSE American: SYN), a late-stage clinical company developing therapeutics designed to preserve the microbiome to protect and restore the health of patients, today announced that it has preliminary agreement from the U.S. […]
AOBiome Therapeutics (“AOBiome”), a clinical-stage life sciences company advancing patented microbiome-based therapies, today announced that AOBiome has expanded its clinical-stage pipeline with the initiation of a randomized, double-blind, Phase 2 study to assess safety, tolerability, […]